Application of Augmented Intelligence for Pharmacovigilance Case Seriousness Determination

INTRODUCTION: Identification of adverse events and determination of their seriousness ensures timely detection of potential patient safety concerns. Adverse event seriousness is a key factor in defining reporting timelines and is often performed manually by pharmacovigilance experts. The dramatic in...

Descripción completa

Detalles Bibliográficos
Autores principales: Routray, Ramani, Tetarenko, Niki, Abu-Assal, Claire, Mockute, Ruta, Assuncao, Bruno, Chen, Hanqing, Bao, Shenghua, Danysz, Karolina, Desai, Sameen, Cicirello, Salvatore, Willis, Van, Alford, Sharon Hensley, Krishnamurthy, Vivek, Mingle, Edward
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965337/
https://www.ncbi.nlm.nih.gov/pubmed/31605285
http://dx.doi.org/10.1007/s40264-019-00869-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6965337/
https://www.ncbi.nlm.nih.gov/pubmed/31605285
http://dx.doi.org/10.1007/s40264-019-00869-4

Ejemplares similares